Hardy, J., Haywood, A., Gogna, G., Martin, J., Yates, P., Greer, R., & Good, P. (2020). Oral medicinal cannabinoids to relieve symptom burden in the palliative care of patients with advanced cancer: A double-blind, placebo-controlled, randomised clinical trial of efficacy and safety of 1:1 delta-9-tetrahydrocannabinol (THC) and cannabidiol (CBD). Current controlled trials in cardiovascular medicine, 21(1), 611-8. https://doi.org/10.1186/s13063-020-04541-6
Citace podle Chicago (17th ed.)Hardy, Janet, Alison Haywood, Gauri Gogna, Jennifer Martin, Patsy Yates, Ristan Greer, a Phillip Good. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine 21, no. 1 (2020): 611-8. https://doi.org/10.1186/s13063-020-04541-6.
Citace podle MLA (9th ed.)Hardy, Janet, et al. "Oral Medicinal Cannabinoids to Relieve Symptom Burden in the Palliative Care of Patients with Advanced Cancer: A Double-blind, Placebo-controlled, Randomised Clinical Trial of Efficacy and Safety of 1:1 Delta-9-tetrahydrocannabinol (THC) and Cannabidiol (CBD)." Current Controlled Trials in Cardiovascular Medicine, vol. 21, no. 1, 2020, pp. 611-8, https://doi.org/10.1186/s13063-020-04541-6.